• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    More On TKPYY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Takeda Pharmaceutical Company Limited (TKPYY)

    -Other OTC
    26.35 Up 0.49(1.89%) 3:47PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Takeda Pharmaceutical Company Limited
    1-1, Doshomachi 4-chome
    Chuo-ku
    Osaka, 540-8645
    Japan - Map
    Phone: 81 6 6204 2111
    Fax: 81 6 6204 2880
    Website: http://www.takeda.co.jp

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:31,225

    Business Summary 

    Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Takeda Pharmaceutical Company Limited

    Key Executives 
     PayExercised
    Mr. Yasuchika Hasegawa , 69
    Chairman and Chief Exec. Officer
    1.81MN/A
    Mr. Francois-Xavier Roger , 53
    Chief Financial Officer, Sr. VP and Director
    3.46MN/A
    Dr. Tadataka Yamada M.D., 69
    Chief Medical & Scientific Officer and Director
    3.03MN/A
    Mr. Yasuhiko Yamanaka ,
    Managing Director of Special Missions and Director
    778.00KN/A
    Mr. Christophe Weber ,
    Pres, Chief Operating Officer and Representative Director
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.